We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
-16.14%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$518M
AUM Growth
-$140M
Cap. Flow
-$19.5M
Cap. Flow %
-3.75%
Top 10 Hldgs %
29.15%
Holding
139
New
12
Increased
23
Reduced
67
Closed
18

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.57M
2
BIIB icon
Biogen
BIIB
+$2.8M
3
NXPI icon
NXP Semiconductors
NXPI
+$1.95M
4
MSFT icon
Microsoft
MSFT
+$1.02M
5
CVX icon
Chevron
CVX
+$971K

Sector Composition

Rank Sector Weight
1 Technology 22.36%
2 Healthcare 20.28%
3 Industrials 13.56%
4 Consumer Discretionary 11.55%
5 Communication Services 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
26
Edwards Lifesciences
EW
$49.6B
$7.12M 1.37%
113,286
-5,625
-5% -$406K
ABT icon
27
Abbott
ABT
$183B
$7.02M 1.35%
88,932
-2,142
-2% -$179K
MCD icon
28
McDonald's
MCD
$192B
$6.97M 1.34%
42,133
-1,832
-4% -$361K
BA icon
29
Boeing
BA
$171B
$6.83M 1.32%
45,792
-397
-0.9% -$109K
HON icon
30
Honeywell
HON
$77B
$6.72M 1.3%
53,314
-742
-1% -$115K
T icon
31
AT&T
T
$159B
$6.4M 1.24%
290,725
-4,461
-2% -$122K
MMM icon
32
3M
MMM
$90.9B
$6.33M 1.22%
55,465
-1,772
-3% -$233K
MKC icon
33
McCormick & Company Non-Voting
MKC
$13.7B
$6.16M 1.19%
87,242
+1,000
+1% +$77.6K
MRK icon
34
Merck
MRK
$322B
$6.03M 1.16%
82,091
+987
+1% +$77.6K
PFE icon
35
Pfizer
PFE
$143B
$5.8M 1.12%
187,187
-5,117
-3% -$174K
PG icon
36
Procter & Gamble
PG
$336B
$5.28M 1.02%
47,974
-85
-0.2% -$10.2K
IBM icon
37
IBM
IBM
$211B
$5.21M 1.01%
49,123
-395
-0.8% -$50K
SYY icon
38
Sysco
SYY
$40.8B
$5.02M 0.97%
110,037
+3,810
+4% +$264K
SCHW
39
Charles Schwab
SCHW
$183B
$4.87M 0.94%
144,919
+1,076
+0.7% +$45.2K
BMY icon
40
Bristol-Myers Squibb
BMY
$133B
$4.82M 0.93%
86,505
-7,162
-8% -$438K
WBA
41
DELISTED
Walgreens Boots Alliance
WBA
$4.8M 0.93%
104,995
+116
+0.1% +$5.89K
STZ icon
42
Constellation Brands
STZ
$22.2B
$4.8M 0.93%
33,461
-1,132
-3% -$200K
ENB icon
43
Enbridge
ENB
$119B
$4.76M 0.92%
163,795
-10,911
-6% -$404K
ABBV icon
44
AbbVie
ABBV
$443B
$4.64M 0.9%
60,862
+4,020
+7% +$342K
GLW icon
45
Corning
GLW
$119B
$4.59M 0.89%
223,684
+5,160
+2% +$135K
LLY icon
46
Eli Lilly
LLY
$1.02T
$4.54M 0.88%
32,695
-575
-2% -$79K
GOOGL icon
47
Alphabet (Google) Class A
GOOGL
$4.36T
$4.52M 0.87%
77,820
-11,980
-13% -$812K
DE icon
48
Deere & Co
DE
$160B
$4.48M 0.86%
32,415
-1,874
-5% -$296K
ADP icon
49
Automatic Data Processing
ADP
$106B
$4.45M 0.86%
32,536
+1,004
+3% +$162K
AMAT icon
50
Applied Materials
AMAT
$403B
$4.15M 0.8%
90,640
-6,165
-6% -$354K

Similar funds

Jacobs & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Jacobs & Co held 139 positions worth $518M, down 21% from $658M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Jacobs & Co withdrew a net $19.5M in Q1 2020, closing 18 positions and reducing 67 holdings. Its most notable exit was Biogen, an estimated $2.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Jacobs & Co opened a new position in Amazon worth $17.6M.

  • Jacobs & Co's largest Q1 2020 buy was Amazon: 180,920 shares worth $17.6M.
  • Jacobs & Co added most to DEUTSCHE TELEKOM AG ADS (1ORD) in Q1 2020, an estimated $590K increase.
  • Jacobs & Co's biggest Q1 2020 reduction was Apple, cutting an estimated $3.57M.
  • Jacobs & Co fully exited Biogen in Q1 2020, selling an estimated $2.8M.
  • Jacobs & Co's ten largest holdings make up 29% of its $518M portfolio in Q1 2020.
  • Jacobs & Co opened 12 new positions and closed 18 in Q1 2020.
  • Jacobs & Co's portfolio value fell 21% quarter-over-quarter to $518M.

Based on Jacobs & Co's 13F filing for Q1 2020, filed 13 Apr 2020.